New Trivalent Influenza Vaccine and Implications for Practitioners

October 6th 2020

Contemporary Clinic spoke with Gregg Sylvester, chief medical officer at Seqirus, about the new trivalent influenza vaccine, aTIV, and its implications for practitioners.

Contemporary Clinic spoke with Gregg Sylvester, chief medical officer at Seqirus, about the new trivalent influenza vaccine, aTIV, and its implications for practitioners.

Sylvester emphasized that vaccines are very important in preventing disease, beyond just influenza. However, if we focus on just influenza, they have evolved and improved over time.

"This adjuvanted trivalent influenza vaccine that we're talking about now was shown in 2017/2018 to actually reduce office visits and hospitalizations compared to the standard flu vaccine," Sylvester said.

Sylvester also discussed the importance of this data for vulnerable populations, implications for practitioners and other health care professionals, and what he hopes to see for the future of aTIV and other vaccines.

Related Content